Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MPI | P34949 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Demannose SCHEMBL1051912 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL14486320 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL15321015 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL20956808 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL20500378 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL14958551 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL6529193 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL13947310 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Galactose SCHEMBL20818999 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1PDE4AAKR1B1 | |
| Demannose SCHEMBL2290731 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1PDE4AAKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113663086-B | Dendritic cell targeted hybrid dendrimer/YTHDF 1siRNA complex and preparation and application thereof | 东华大学 | 2023-06-23 | — | — | CN | claimed |
| EP-3362794-B1 | METHODS FOR DIAGNOSING INFECTIOUS DISEASES USING ADSORPTION MEDIA | EXTHERA MEDICAL CORP (US) | 2023-06-07 | — | — | EP | claimed |
| EP-1639142-B1 | A METHOD FOR RECOVERING GALACTOSE FROM A SOLUTION DERIVED FROM PLANT-BASE BIOMASS USING CHROMATOGRAPHIC FRACTIONATION STEPS AND CRYSTALLISATION | DUPONT NUTRITION BIOSCI APS (DK) | 2015-07-22 | — | — | EP | claimed |
| EP-1468121-B1 | METHOD FOR THE RECOVERY OF SUGARS | DANISCO (DK) | 2011-11-09 | — | — | EP | claimed |
| CN-117089479-A | Lactic acid bacteria agent suitable for pasture and straw mixed silage and application thereof | 贵州省草地技术试验推广站 | 2023-11-21 | — | — | CN | disclosed |
| CN-116376767-A | Biocontrol strain, microbial inoculum containing biocontrol strain and application of biocontrol strain | 沈阳农业大学 | 2023-07-04 | — | — | CN | disclosed |
| CN-113663086-B | Dendritic cell targeted hybrid dendrimer/YTHDF 1siRNA complex and preparation and application thereof | 东华大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-115724938-A | DM 9-domain-containing recombinant protein rCgDM9CP-7 of crassostrea gigas and application thereof | 大连海洋大学 | 2023-03-03 | — | — | CN | disclosed |
| CN-115572700-A | Pseudomonas mendelia strain with induced disease resistance and application thereof | 沈阳农业大学 | 2023-01-06 | — | — | CN | disclosed |
| WO-2017185180-A1 | THERAPEUTICALLY TRIGGERING AN INNATE IMMUNE RESPONSE IN A TARGET TISSUE | QU BIOLOGICS INC. (CA) | 2017-11-02 | — | — | WO | disclosed |
| EP-2760477-A1 | DI-ALIPHATIC SUBSTITUTED PEGYLATED LIPIDS | Alnylam Pharmaceuticals, Inc. (US) | 2014-08-06 | — | — | EP | disclosed |
| WO-2013049328-A9 | DI-ALIPHATIC SUBSTITUTED PEGYLATED LIPIDS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2013-12-27 | — | — | WO | disclosed |
| WO-2009142822-A2 | 2-F MODIFIED RNA INTERFERENCE AGENTS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2009-11-26 | — | — | WO | disclosed |
| EP-1625138-A2 | PROTECTED MONOMERS | Alnylam Pharmaceuticals Inc. (US) | 2006-02-15 | — | — | EP | disclosed |
| EP-1615611-A2 | iRNA CONJUGATES | Alnylam Pharmaceuticals Inc. (US) | 2006-01-18 | — | — | EP | disclosed |
| WO-2004094345-A2 | PROTECTED MONOMERS | ALNYLAM PHARMACEUTICALS INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| WO-2004091515-A2 | iRNA CONJUGATES | ALNYLAM PHARMACEUTICALS, INC. (US) | 2004-10-28 | — | — | WO | disclosed |
| EP-0584206-A1 | GENETIC CONTROL OF ACETYLATION AND PYRUVYLATION OF XANTHAN BASED POLYSACCHARIDE POLYMERS | GETTY SCIENTIFIC DEVELOPMENT COMPANY (US) | 1994-03-02 | — | — | EP | disclosed |
| WO-1992019753-A1 | GENETIC CONTROL OF ACETYLATION AND PYRUVYLATION OF XANTHAN BASED POLYSACCHARIDE POLYMERS | GETTY SCIENTIFIC DEVELOPMENT COMPANY (US) | 1992-11-12 | — | — | WO | disclosed |
| EP-0115631-A1 | Separation of mannose by selective adsorption on zeolitic molecular sieves | UNION CARBIDE CORPORATION (US) | 1984-08-15 | — | — | EP | disclosed |